<DOC>
	<DOCNO>NCT01860820</DOCNO>
	<brief_summary>This randomize , control trial involve kidney kidney pancreas transplant patient . There 2 group patient randomize one two ; one receive standard care IPC TED stocking help circulation , group use geko device new device Health Canada approval . Clinical outcome compare group clinical difference patient receive routine medical therapy IPC/TEDS versus Geko device also evaluate .</brief_summary>
	<brief_title>The Effect Neuromuscular Stimulation Post-Transplant Leg Edema</brief_title>
	<detailed_description />
	<mesh_term>Edema</mesh_term>
	<criteria>Male female At least 18 year old Undergoing kidney kidney pancreas transplant surgery recipient Able willing provide write informed consent Absence know peripheral vascular disease Body Mass Index 18 34 Leg circumference site gekoâ„¢ device placement 24 '' less History deep vein thrombosis Temporary permanent cardiac pace Patient pregnant Any patient may exclude way warning Manufacturer 's Instructions Use Any patient require ECG electrode apply leg continuous monitor throughout therapy Previous leg ( ) amputation Presence follow site intend device placement : cancerous lesion , swell infect inflamed area skin eruption i.e . phlebitis , thrombophlebitis , varicose vein History sign haematological disorder ( especially relation clot coagulation disorder ) include presence history thrombus formation BMI index &gt; 36 Patients neurological disorder disease would interfere proper assessment conduct trial History implantable brain stimulator Patients tolerate stimulation GEKO device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>IPC/TEDS</keyword>
	<keyword>Geko device</keyword>
</DOC>